Bank of America’s GE HealthCare GEHC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$208M Sell
3,249,771
-882,969
-21% -$58M 0.01% 770
2026
Q1
$294M Sell
4,132,740
-266,484
-6% -$21M 0.02% 570
2025
Q4
$361M Sell
4,399,224
-821,632
-16% -$64M 0.03% 506
2025
Q3
$392M Buy
5,220,856
+1,058,853
+25% +$79M 0.03% 523
2025
Q2
$308M Buy
4,162,003
+1,281,613
+44% +$89.2M 0.02% 601
2025
Q1
$232M Buy
2,880,390
+113,111
+4% +$9.72M 0.02% 662
2024
Q4
$216M Sell
2,767,279
-135,925
-5% -$11.6M 0.02% 646
2024
Q3
$272M Buy
2,903,204
+272,273
+10% +$22.9M 0.02% 599
2024
Q2
$205M Buy
2,630,931
+24,975
+1% +$2.04M 0.02% 668
2024
Q1
$237M Buy
2,605,956
+1,296,962
+99% +$108M 0.02% 604
2023
Q4
$101M Sell
1,308,994
-168,347
-11% -$11.8M 0.01% 966
2023
Q3
$101M Buy
1,477,341
+78,762
+6% +$5.73M 0.01% 889
2023
Q2
$114M Sell
1,398,579
-148,393
-10% -$11.8M 0.01% 828
2023
Q1
$127M Buy
+1,546,972
New +$110M 0.01% 817

Other funds holding GEHC

Bank of America's GEHC Position: Q2 2026 in Review

Bank of America reduced its GE HealthCare (GEHC) stake by 21% in Q2 2026, selling an estimated $58M and leaving 3,249,771 shares worth $208M. The position accounts for 0.01% of the portfolio, ranked #770.

Bank of America first reported a position in GEHC in Q1 2023 and has held it in 14 quarters since. The position peaked at $392M in Q3 2025. 1,221 funds tracked by Wall St. Rank hold GEHC as of Q2 2026.

  • Bank of America held 3,249,771 shares of GE HealthCare worth $208M as of Q2 2026.
  • Bank of America sold 882,969 GE HealthCare shares in Q2 2026, an estimated $58M.
  • GE HealthCare made up 0.01% of Bank of America's portfolio in Q2 2026, its #770 holding.
  • Bank of America first reported a position in GE HealthCare in Q1 2023 and has held it in 14 quarters since.
  • Bank of America's GE HealthCare position peaked at $392M in Q3 2025.
  • 1,221 funds tracked by Wall St. Rank held GE HealthCare as of Q2 2026.

Based on Bank of America's 13F filing for Q2 2026, filed 14 Aug 2026.